Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$28.98 0.20 (0.69%)
2/9/2010 4:00 PM

Forest Laboratories, Inc. (FRX)

CAPS Rating:
****

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating FRX

Add Stock to Watchlist

What the Community Thinks

Total Members

518 Outperforms
28 Underperforms
 

All-Stars

212 Outperforms
8 Underperforms
 

Wall Street

16 Outperforms
2 Underperforms
 

Members bullish on FRX are also bullish on:

Members bearish on FRX are also bearish on:

Ticker Tags

S&P 500 (499), Mid Cap (610), Pharmaceuticals (149), Defensive (1457), Healthcare (711)
Suggest a tag

Forest Laboratories, Inc. At A Glance

Current Price: $28.98
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $28.78
Daily Range: $28.70 - $29.23
52-Week Range: $18.37 - $33.10
Volume: 2,663,391
Market Cap: $8.75B
P/E Ratio: 11.51
Compare Our Special Broker Offers!

Stock Trends

FRX VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

1

Forest Laboratories, Inc. (FRX)

Avatar FoolishJayhawk (23.71) Submitted: 6/12/09 2:25 PM

From http://lonelyvalue.blogspot.com/2009/06/see-forest-labs-for-its-cash.html

As the blogger at Lonely Value puts it:

"Even if Lexipro disappears in a few years, Forest Labs is ridiculously valued. It's priced for liquidation (or worse). What is the investment community missing? Can they count? ...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Forest Laboratories, Inc. (FRX)

Avatar KevinO3826 (46.91) Submitted: 10/24/06 11:19 PM

Should be retracing now with divergence signals already displayed

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 62 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (FRX)

Avatar sleepingdragon (40.93) Submitted: 2/02/10 2:23 AM : Outperform Start Price: $29.43 FRX Score: -0.75

Selling at a very cheap price. Should be able to come with something to overcome pipeline problems.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar Larchmont (84.62) Submitted: 1/15/10 8:44 AM : Outperform Start Price: $31.35 FRX Score: -1.01

MFI

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar BLAYNE100 (96.43) Submitted: 11/16/09 8:42 PM : Outperform Start Price: $28.89 FRX Score: 3.65

health care will be leading sector in 2010, this company is positioned nicely to benefit

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar jerseytix (79.68) Submitted: 9/28/09 2:42 PM : Outperform Start Price: $29.23 FRX Score: -1.79

Great balance sheet, good product line and a diversified product line with licenses with a number of major drugmakers. Screaming buy.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (FRX)

Avatar sumbawa (30.14) Submitted: 9/11/09 1:10 PM : Outperform Start Price: $28.95 FRX Score: -2.92

Around 5-yr low, easily worth 2x current price, and a decent drug pipeline.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 62 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 18 of 18  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJGreenblatt 75.50 06/12/09 Outperform 1Y $24.23+19.60%+14.80%+4.80 Toggle the visibility of 60-Second Pitch and replies
TrackRBCCapMkts 86.33 04/23/09 Underperform NS $21.85+32.63%+27.91%-4.73
TrackWedbush 66.12 03/26/09 Outperform NS $22.02+31.61%+31.72%-0.11
TrackJimCramer < 20 01/22/09 Outperform 3W $25.16+15.18%+31.87%-16.68
TrackStanfordRes 85.54 09/25/08 Underperform NS $27.83+4.13%-7.95%-12.08
TrackBerkowitz 83.78 08/27/08 Outperform 1Y $36.89-21.44%-13.27%-8.17 Toggle the visibility of 60-Second Pitch and replies
TrackLazardCapit < 20 04/16/08 Outperform NS $35.51-18.39%-16.95%-1.44
TrackRichPzena 38.72 03/31/08 Outperform NS $40.01-27.57%-14.84%-12.73 Toggle the visibility of 60-Second Pitch and replies
TrackDreman 93.64 12/31/07 Outperform NS $36.45-20.49%-23.57%+3.08 Toggle the visibility of 60-Second Pitch and replies
TrackRothCapital 80.39 12/24/07 Outperform NS $36.70-21.04%-24.91%+3.88
TrackSoleil 93.91 12/18/07 Outperform NS $37.40-22.51%-23.11%+0.60
TrackEdwardOwens 98.91 09/30/07 Outperform NS $37.29-22.28%-26.38%+4.09 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 82.08 09/06/07 Outperform NS $41.90-30.84%-23.71%-7.12
TrackPacificGrow 89.01 07/23/07 Outperform NS $44.50-34.88%-26.82%-8.06
TrackBroadpoint.AmTech 76.97 05/23/07 Outperform NS $56.64-48.83%-25.89%-22.95
TrackMatrix 90.36 11/20/06 Outperform NS $48.50-40.25%-18.85%-21.39
TrackLehmanBros 85.06 10/16/06 Outperform NS $52.65-44.96%-16.63%-28.32
TrackSusquehanna 74.67 08/17/06 Outperform NS $47.25-38.67%-11.14%-27.53

Results 1 - 18 of 18  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 906ms